CVI Holdings’s Cellectis CLLS Stock Holding History

CVI Holdings’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-129,434	Closed	-$250K	–	287
2023 Q1	$250K	Buy	+129,434	New	+$324K	0.09%	132

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

CVI Holdings's CLLS Position: Q2 2023 in Review

CVI Holdings sold out of Cellectis (CLLS) in Q2 2023, closing a stake of 129,434 shares — an estimated $250K sold.

CVI Holdings first reported a position in CLLS in Q1 2023 and held it in 1 quarter. The position peaked at $250K in Q1 2023. 35 funds tracked by Wall St. Rank hold CLLS as of Q2 2023.

CVI Holdings reported no remaining Cellectis position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 129,434 Cellectis shares in Q2 2023, an estimated $250K.
CVI Holdings first reported a position in Cellectis in Q1 2023 and held it in 1 quarter.
CVI Holdings's Cellectis position peaked at $250K in Q1 2023.
35 funds tracked by Wall St. Rank held Cellectis as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.